Powered by

Teleflex Reports 250,000 Patients Treated for Enlarged Prostate With the Minimally Invasive UroLift® System

Mar 09, 2021 - GlobeNewswire

WAYNE, Pa., March 09, 2021 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) today announced that, globally, 250,000 patients have been treated with the UroLift ® System, a proven, minimally invasive approach to treating benign prostatic hyperplasia (BPH).

In the United States alone, more than 42 million men are affected by BPH and approximately 12 million men are under a doctor’s care for the condition. 1 This common, non-cancerous enlargement of the prostate occurs as men age ...